Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.86 +0.01 (+0.11%)
As of: Oct 22, 2026 · 3:48 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) EBIT (2024 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded EBIT of -$2.68 million in Q2 2026, compared with -$799,890 a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) EBIT (2024 - 2026) Analysis & Trends

On a TTM basis, Aspire Biopharma Holdings' EBIT came in at -$7.32 million as of Jun 30, 2026; for FY2025, it was -$19.35 million.

  • Across earlier years, EBIT came in at -$1.21 million in FY2024 and -$349,623 in FY2023.
  • The Q2 2026 figure is the lowest quarterly EBIT since Q1 2025.
  • Per Business Quant, the preceding three quarters came in at -$1.65 million (Q1 2026), -$1.85 million (Q4 2025) and -$1.15 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.68 Mn
Mar 31, 2026 -1.65 Mn
Dec 31, 2025 -1.85 Mn
Sep 30, 2025 -1.15 Mn
Jun 30, 2025 -799,890.00
Mar 31, 2025 -15.56 Mn
Dec 31, 2024 -667,722.00
Sep 30, 2024 -215,256.00
API Access

Aspire Biopharma Holdings, Inc. EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ASBP&period=max&api_key=YOUR_API_KEY